AI-Powered QA in Healthcare Software: Leveraging Predictive Analytics and Digital Twins for Safe, Cost-Effective, and Agile Medical Systems

Abstract

Quality assurance (QA) is essential for maintaining reliability, safety, and regulatory compliance of healthcare software systems. In a time when patient care relies heavily on digital infrastructure, such as electronic health records (EHRs), clinical decision support systems, medical device firmware, and telemedicine platforms, software faults can result in life-threatening outcomes. Conventional quality assurance methodologies, based on manual testing and rigid automation frameworks, are inadequate for the contemporary, highly dynamic, interconnected, and data-intensive healthcare landscape. This study examines the revolutionary impact of artificial intelligence (AI) on healthcare quality assurance. We specifically concentrate on two technologies: predictive analytics and digital twins. Predictive analytics enables QA teams to anticipate defect-prone code sections, enhance testing priorities, and proactively avert errors before deployment. Digital twins, as virtual representations of healthcare systems and operations, offer ongoing simulation-based validation across various situations, including unusual or high-risk illnesses. Collectively, these methodologies facilitate a transformation towards secure, economical, and adaptable medical systems. We create a conceptual framework for incorporating predictive analytics and digital twins into agile QA procedures by synthesizing ideas from current academic research and industrial applications. We further elucidate these concepts through healthcare-specific case analyses, including ICU monitoring systems and clinical decision support, which exhibit significant enhancements in defect identification, regulatory adherence, and cost reduction. Our research indicates that AI-driven quality assurance can decrease QA expenses by as much as 40%, expedite release cycles by 30%, and significantly improve patient safety by reducing undetected flaws in essential medical software. The paper concludes with suggestions for industry implementation, regulatory incorporation, and avenues for future research.